ENTRY       D12723                      Drug
NAME        Nedosiran sodium (USAN);
            Rivfloza (TN)
FORMULA     C662H865F19N231O413P57S6.57Na
EXACT_MASS  22285.1018
MOL_WEIGHT  22295.5323
EFFICACY    Hepatic lactate dehydrogenase level lowering agent
  DISEASE   Primary hyperoxaluria type 1 [DS:H00117]
  TYPE      RNA interference (RNAi) drug
COMMENT     Treatment of primary hyperoxaluria
TARGET      LDHA [HSA:3939] [KO:K00016] (mRNA)
BRITE       Target-based classification of drugs [BR:br08310]
             Enzymes
              Oxidoreductases (EC1)
               Dehydrogenases
                LDHA
                 D12723  Nedosiran sodium (USAN)
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D12723
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D12723
DBLINKS     CAS: 2247026-22-6
///
